Episode 41

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Featuring an interview with Prof Martin Reck, including the following topics:

  • Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
  • Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
  • Considerations with maintenance therapy for ES-SCLC (9:31)
  • Considerations with immunotherapy for ES-SCLC (13:12)
  • Curability of SCLC with systemic therapy (15:17)
  • Data with chemoimmunotherapy for patients with poor performance status (25:55)
  • Future developments in therapy for SCLC (30:11)
  • Rapid fire: Small Cell 101 (35:45)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free